Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:1222-1229

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, T.-S.
Right arrow Articles by Chau, L.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, T.-S.
Right arrow Articles by Chau, L.-Y.
Related Collections
Right arrow Nutrition
Right arrow Pathophysiology
Right arrow Oxidant stress

(Circulation. 1999;99:1222-1229.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Iron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice

Tzong-Shyuan Lee, MS; Ming-Shi Shiao, PhD; Ching-Chien Pan, BS; Lee-Young Chau, PhD

From the Division of Cardiovascular Research, Institute of Biomedical Sciences, Academia Sinica (T.-S.L., C.-C.P., L.-Y.C.), and the Lipid Metabolism Laboratory, Department of Medical Research and Education, Veterans General Hospital (M.-S.S.), Taipei, Taiwan, ROC.

Correspondence to Lee-Young Chau, PhD, Division of Cardiovascular Research, Institute of Biomedical Sciences, Academia Sinica, Nankang, Taipei, 11529, Taiwan, ROC. E-mail lyc{at}mail.ibms.sinica.edu.tw

Background—Iron deposition is evident in human atherosclerotic lesions, suggesting that iron may play a role in the development of atherosclerosis. To test this idea, the correlation between the extent of iron deposition and the severity of atherosclerosis in apolipoprotein E (apoE)-deficient mice was investigated. Furthermore, the effect of a low-iron diet on the progression of atherosclerotic lesions in these animals was evaluated.

Methods and Results—Iron deposition in tissues of apoE-deficient mice was examined by Perls' staining method. The results clearly demonstrated that iron deposits are present in atherosclerotic lesions and tissue sections of heart and liver in an age-dependent manner. When the young mice received a low-iron diet for 3 months, the hematocrit, serum iron, hemoglobin, and cholesterol concentrations were not significantly altered compared with those of littermates placed on a chow diet. However, the serum ferritin level of animals in the iron-restricted group was 27% to 30% lower than that of the control group in either sex. Furthermore, the lipoproteins isolated from the iron-restricted group exhibited greater resistance to copper-induced oxidation. Histological examination revealed that atherosclerotic lesions developed in mice fed a low-iron diet were significantly smaller than those found in control littermates. Likewise, the iron deposition as well as tissue iron content was much less in aortic tissues of the iron-restricted animals. Circulating autoantibodies to oxidized LDL and immunostains for epitopes of malondialdehyde-modified LDL detected on lesions were also significantly lower in mice fed a low-iron diet.

Conclusions—Iron deposition is closely associated with the progression of atherosclerosis in apoE-deficient mice. Restriction in dietary iron intake leads to significant inhibition of lesion formation in these animals. These results suggest that the beneficial effect of a low-iron diet may be mediated, at least in part, by the reduction of iron deposition as well as LDL oxidation in vascular lesions.


Key Words: atherosclerosis • iron • lipoproteins • oxygen




This article has been cited by other articles:


Home page
BMJHome page
S. Stranges and E. Guallar
Dietary iron and blood pressure
BMJ, July 15, 2008; 337(jul15_1): a547 - a547.
[Full Text]


Home page
Exp. Biol. Med.Home page
W. Li, L.-H. Xu, C. Forssell, J. L. Sullivan, and X.-M. Yuan
Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques
Experimental Biology and Medicine, July 1, 2008; 233(7): 818 - 826.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. l. Sullivan
Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Experimental Biology and Medicine, September 1, 2007; 232(8): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. B. Hu
The Iron-Heart Hypothesis: Search for the Ironclad Evidence
JAMA, February 14, 2007; 297(6): 639 - 641.
[Full Text] [PDF]


Home page
Vasc MedHome page
L. M Yunker, J. S Parboosingh, H. E Conradson, P. Faris, P. J Bridge, J. Buithieu, L. M Title, F. Charbonneau, S. Verma, E. M Lonn, et al.
The effect of iron status on vascular health
Vascular Medicine, May 1, 2006; 11(2): 85 - 91.
[Abstract] [PDF]


Home page
CirculationHome page
D. L. van der A, J. J.M. Marx, D. E. Grobbee, M. H. Kamphuis, N. A. Georgiou, J. H. van Kats-Renaud, W. Breuer, Z. I. Cabantchik, M. Roest, H. A.M. Voorbij, et al.
Non-Transferrin-Bound Iron and Risk of Coronary Heart Disease in Postmenopausal Women
Circulation, April 25, 2006; 113(16): 1942 - 1949.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Ishizaka, K. Saito, I. Mori, G. Matsuzaki, M. Ohno, and R. Nagai
Iron Chelation Suppresses Ferritin Upregulation and Attenuates Vascular Dysfunction in the Aorta of Angiotensin II-Infused Rats
Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2282 - 2288.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. L. Sullivan
Stored Iron and Vascular Reactivity
Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1532 - 1535.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Zheng, R. Cable, B. Spencer, N. Votto, and S. D. Katz
Iron Stores and Vascular Function in Voluntary Blood Donors
Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1577 - 1583.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. S. Meir and E. Leitersdorf
Atherosclerosis in the Apolipoprotein E-Deficient Mouse: A Decade of Progress
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1006 - 1014.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Wolff, H. Volzke, J. Ludemann, D. Robinson, D. Vogelgesang, A. Staudt, C. Kessler, J. B. Dahm, U. John, and S. B. Felix
Association Between High Serum Ferritin Levels and Carotid Atherosclerosis in the Study of Health in Pomerania (SHIP)
Stroke, February 1, 2004; 35(2): 453 - 457.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Troen, E. Lutgens, D. E. Smith, I. H. Rosenberg, and J. Selhub
The atherogenic effect of excess methionine intake
PNAS, December 9, 2003; 100(25): 15089 - 15094.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
V. S Chekanov, M. Zargarian, I. Baibekov, P. Karakozov, G. Tchekanov, J. Hare, V. Nikolaychik, T. Bajwa, and M. Akhtar
Deferoxamine-fibrin accelerates angiogenesis in a rabbit model of peripheral ischemia
Vascular Medicine, August 1, 2003; 8(3): 157 - 162.
[Abstract] [PDF]


Home page
Vasc MedHome page
G. Ramakrishna, T. W Rooke, and L. T Cooper
Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light
Vascular Medicine, August 1, 2003; 8(3): 203 - 210.
[Abstract] [PDF]


Home page
CirculationHome page
S. M. Day, D. Duquaine, L. V. Mundada, R. G. Menon, B. V. Khan, S. Rajagopalan, and W. P. Fay
Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis
Circulation, May 27, 2003; 107(20): 2601 - 2606.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
R Surber, H H Sigusch, H Kuehnert, and H R Figulla
Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography
J. Med. Genet., May 1, 2003; 40(5): e58 - 58.
[Full Text] [PDF]


Home page
CirculationHome page
N. Ishizaka, K. Saito, H. Mitani, I. Yamazaki, M. Sata, S.-i. Usui, I. Mori, M. Ohno, and R. Nagai
Iron Overload Augments Angiotensin II-Induced Cardiac Fibrosis and Promotes Neointima Formation
Circulation, October 1, 2002; 106(14): 1840 - 1846.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. M. Fernandez-Real, A. Lopez-Bermejo, and W. Ricart
Cross-Talk Between Iron Metabolism and Diabetes
Diabetes, August 1, 2002; 51(8): 2348 - 2354.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S.-H. Juan, T.-S. Lee, K.-W. Tseng, J.-Y. Liou, S.-K. Shyue, K. K. Wu, and L.-Y. Chau
Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice
Circulation, September 25, 2001; 104(13): 1519 - 1525.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Duffy, E. S. Biegelsen, M. Holbrook, J. D. Russell, N. Gokce, J. F. Keaney Jr, and J. A. Vita
Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease
Circulation, June 12, 2001; 103(23): 2799 - 2804.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. W. Choi, S. K. Kim, and S. H. Pai
Changes in Serum Lipid Concentrations during Iron Depletion and after Iron Supplementation
Ann. Clin. Lab. Sci., April 1, 2001; 31(2): 151 - 156.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Sullivan
Iron and the Genetics of Cardiovascular Disease
Circulation, September 21, 1999; 100(12): 1260 - 1263.
[Full Text] [PDF]